Psychophysical evidence for rod vulnerability in age-related macular degeneration. - Wikidata - awgldk - TriplyDB

Psychophysical evidence for rod vulnerability in age-related macular degeneration.

Psychophysical evidence for rod vulnerability in age-related macular degeneration.

http://www.wikidata.org/entity/Q40782295

about

Violet and blue light blocking intraocular lenses: photoprotection versus photoreception Scotopic microperimetry in the early diagnosis of age-related macular degeneration: preliminary study.The human rhodopsin kinase promoter in an AAV5 vector confers rod- and cone-specific expression in the primate retina.Multimodal assessment of microscopic morphology and retinal function in patients with geographic atrophy.Age-related macular degeneration--emerging pathogenetic and therapeutic concepts.Night vision symptoms and progression of age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial.Driving and Age-Related Macular Degeneration.A short-duration dark adaptation protocol for assessment of age-related maculopathy Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health Quantification of visual field loss in age-related macular degeneration.Diagnostic sensitivity and specificity of dark adaptometry for detection of age-related macular degeneration.Visual contrast sensitivity in patients with impairment of functional independence after stroke.Delayed Rod-Mediated Dark Adaptation Is a Functional Biomarker for Incident Early Age-Related Macular Degeneration.Retinal specific measurement of dark-adapted visual function: validation of a modified microperimeter.Persons with age-related maculopathy risk genotypes and clinically normal eyes have reduced mesopic vision Endophenotypes for Age-Related Macular Degeneration: Extending Our Reach into the Preclinical Stages of Disease.Colour vision testing as an aid to diagnosis and management of age related maculopathy.Autofluorescence imaging with near-infrared excitation:normalization by reflectance to reduce signal from choroidal fluorophores.Spare the rod and spoil the eye.Relationship between slow visual processing and reading speed in people with macular degeneration.Serum levels of lipid metabolites in age-related macular degeneration.Microperimetry and fundus autofluorescence in patients with early age-related macular degeneration.Relationship between retinal layer thickness and the visual field in early age-related macular degeneration.Comparison of Visual Function in Older Eyes in the Earliest Stages of Age-related Macular Degeneration to Those in Normal Macular Health Impairments in Dark Adaptation Are Associated with Age-Related Macular Degeneration Severity and Reticular Pseudodrusen Visual Function in Older Eyes in Normal Macular Health: Association with Incident Early Age-Related Macular Degeneration 3 Years Later.Age-related macular degeneration: a target for nanotechnology derived medicines Assessment of age changes and repeatability for computer-based rod dark adaptation.Assessment of multifocal electroretinogram abnormalities and their relation to morphologic characteristics in patients with large drusen.Cone-mediated multifocal electroretinogram in age-related macular degeneration: progression over a long-term follow-up.Evaluating the performance of the quick CSF method in detecting contrast sensitivity function changes Therapeutic margins in a novel preclinical model of retinitis pigmentosa.Can HMG Co-A reductase inhibitors ("statins") slow the progression of age-related macular degeneration? The age-related maculopathy statin study (ARMSS)Loss of protein kinase Cgamma in knockout mice and increased retinal sensitivity to hyperbaric oxygen.Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration.Examining the association between age-related macular degeneration and motor vehicle collision involvement: a retrospective cohort study.Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging.Mid-stage intervention achieves similar efficacy as conventional early-stage treatment using gene therapy in a pre-clinical model of retinitis pigmentosa Ultraviolet or blue-filtering intraocular lenses: what is the evidence?CLINICAL ENDPOINTS FOR THE STUDY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION.

P2860

Q24676430-7F425B9B-A804-42F0-8727-A2862DB04A4A Q30422343-D0CDADD5-CDEE-445C-A9C7-E9E698E2C0D1 Q30525669-A59B7225-6D28-4D2A-A416-7B3CF5A944F9 Q30540956-D88F7474-D2DA-41F6-8876-82E66713BB36 Q33263472-DBB7ACB9-8009-46B9-8690-4EABE8DA86AD Q33356851-C719907B-9CFD-4142-BE13-7FE54045ED91 Q33565104-2B9035FD-8BCA-48EB-B1F9-D0B2483FD212 Q33574618-62629ECC-02A6-4636-A58D-460CCA1E78FA Q34003267-D9D08F59-D5C2-4177-B739-8B5E318A8597 Q34328442-D6B50B18-2E63-44D5-A8DA-2AF0505B9FCE Q34405206-630CA13F-1497-4816-BB78-DB02A5CC7C82 Q34413084-AAC0C8C3-6179-4D1D-8A0B-D5940BD84AD9 Q34500095-42001913-951F-4A1D-A21E-AA05CD55FA94 Q34593277-03754456-C4DC-4432-83A2-F5625325B1D1 Q34645603-D6B073DE-A4E3-4D7A-BECD-20E5C4940508 Q34825031-A44F2B5B-496A-4E3F-AC2F-C4D3C310166D Q35592384-71439D4B-10CE-4C1F-BB8C-8A251C1B1856 Q35682509-40ACD393-7A33-41EB-BEAB-461ADB8B12A9 Q36143737-FC57AD43-5BEB-4923-A56F-4B1ECDD975FB Q36169954-5311204A-3644-4BCE-AD11-90E331FC1855 Q36171270-C4D137D7-6F39-4A01-9D1C-0A3C1A486869 Q36172092-85914E27-5EDA-4E02-9780-110B4DA5D438 Q36391547-82DE7222-9CF6-45CA-86F3-E31836243550 Q36535118-FBC87D1E-F534-4384-BED8-68460B00C17D Q36811078-52A521B2-50DB-40D3-A81A-DCD18CEDD5F4 Q36848556-E44E6CEE-B810-4178-A50D-080AC4690E8C Q36920435-0FCDF227-AF44-4FD7-8839-8D07640A1F3B Q36927563-2E39C21C-842B-4231-B7F9-A1DE831D70BB Q36969380-B384E628-661F-4CB2-95ED-CD63BA56149D Q36973459-4C4ECB5C-14CD-411C-BCC4-8C6576FC7EFF Q36981882-CC6091F2-533B-4CE4-8115-65581DB48C43 Q37093907-3B5EDC27-9FBD-4294-AD67-539C2E2E7365 Q37192985-934DA614-40CA-4FA1-B60E-F1723DF28DF0 Q37243724-1538D0F9-AA7D-44EA-95C3-8F811095041B Q37314763-DF6C52E3-F5A2-457C-A380-C959494C841D Q37334899-13A88647-9F28-4E74-A43F-904296FCCF46 Q37395303-7FD60F5C-D4D7-416F-892A-657D3155E962 Q37406449-7D360A57-DFCF-4C77-BE56-D478A6E20876 Q38592751-2FBAFDC6-B6E4-457B-AC0E-A5D3EA8F4544 Q38818680-2D3CD38C-7E99-4BDC-A984-FD9F0719963B

P2860

Psychophysical evidence for rod vulnerability in age-related macular degeneration.

http://www.wikidata.org/entity/Q40782295

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

2000年學術文章

@zh

2000年學術文章

@zh-hant

name

Psychophysical evidence for rod vulnerability in age-related macular degeneration.

@en

type

label

Psychophysical evidence for rod vulnerability in age-related macular degeneration.

@en

prefLabel

Psychophysical evidence for rod vulnerability in age-related macular degeneration.

@en

P1433

Q40782295-F3FE8ABA-211A-4B88-93FB-3F44C555DBBB

P1476

Q40782295-B93133CC-724D-4989-8B1C-2F4C8A962004

P2093

Q40782295-154FB4C0-E66C-4C35-A63A-54E8B3F98D1F

Q40782295-177B7792-2980-486D-AC31-3E31C3B6AB43

Q40782295-3832592A-B915-4C68-B18A-754745618803

Q40782295-65741643-89E2-40E2-8350-2A468DB9EF73

Q40782295-79C565FC-766A-4B38-8D09-F360AA7E2C79

Q40782295-99F47801-D750-4FE9-9DF8-CB65A00BB57E

Q40782295-B4EF42BB-ABD0-4CB0-863E-F86155E1016D

Q40782295-BFDB43A5-BFDC-48C2-A12B-821424362602

Q40782295-FFB863B1-8068-4AA2-AB95-54CBACDA8E3D

P304

Q40782295-34221F0D-36F4-4909-BA2B-F68DB7C53339

P31

Q40782295-4E4BCD5F-90D1-4F3C-BDA9-92EFCCA622BC

P407

Q40782295-185606FA-F292-4483-A19F-2DE48AC2A181

P433

Q40782295-08978660-39A1-4DD4-9F80-03BE758EC53B

P478

Q40782295-ACDF829A-C19B-4E3D-9B5B-2435856A5D0F

P577

Q40782295-7E24358E-0265-4F6A-A564-4FAFF01E8D46

P698

Q40782295-2A503236-8B7B-4F72-AC62-BA2C470BE341

P1433

Investigative Ophthalmology & Visual Science

P1476

Psychophysical evidence for rod vulnerability in age-related macular degeneration.

@en

P2093

Cideciyan AV

http://www.w3.org/2001/XMLSchema#string

Fine SL

http://www.w3.org/2001/XMLSchema#string

Ho AC

http://www.w3.org/2001/XMLSchema#string

Huang Y

http://www.w3.org/2001/XMLSchema#string

Jackson GR

http://www.w3.org/2001/XMLSchema#string

Jacobson SG

http://www.w3.org/2001/XMLSchema#string

Lolley V

http://www.w3.org/2001/XMLSchema#string

Maguire MG

http://www.w3.org/2001/XMLSchema#string

Owsley C

http://www.w3.org/2001/XMLSchema#string

P304

267-273

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2000-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10634630

http://www.w3.org/2001/XMLSchema#string